Atlas Trials

177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk Prostate Cancer

Clinical trial NCT06449781 · RECRUITING

Trial details

NCT number
NCT06449781
Sponsor
Maria Sklodowska-Curie National Research Institute of Oncology
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2025-01-09
Primary completion
2030-11-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.